A Safety, Tolerability and Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms
Condition(s):Relapsed or Refractory Acute Myeloid Leukemia; Relapsed or Refractory Chronic Myelomonocytic Leukemia; Relapsed or Refractory Myelodysplastic SyndromeLast Updated:March 20, 2024Recruiting